✦ LIBER ✦

The impact of cyclosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients

✍ Scribed by Wiesner, Russell H. ;Goldstein, Robert M. ;Donovan, Jeremiah P. ;Miller, Charles M. ;Lake, John R. ;Lucey, Michael R.

Publisher: Wiley (John Wiley & Sons)
Year: 1998
Tongue: English
Weight: 134 KB
Volume: 4
Category: Article
ISSN: 1074-3022
DOI: 10.1002/lt.500040105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Schistosoma mansoni infection in the liv

Schistosoma mansoni infection in the liver graft: The impact on donor and recipient outcomes after transplantation

✍ Rodrigo Vincenzi; João Seda Neto; Eduardo A. Fonseca; Vincenzo Pugliese; Katia R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

The increasing number of transplants performed each year has led to the identification of unusual diseases in liver grafts from asymptomatic donors that were unrecognized before liver transplantation. Here we report our experience with patients who received liver grafts infected with schistosomiasis

Patient and graft survival in hepatitis

Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States

✍ Mark W. Russo; Joseph Galanko; Kimberly Beavers; Michael W. Fried; Roshan Shrest 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

End stage liver disease from chronic hepatitis C is the leading indication for liver transplantation in the United States. Small studies suggest that recurrent hepatitis C may be more common and occur earlier after living donor liver transplantation compared to deceased donor liver transplantation.

Recipient and donor factors influence th

Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients

✍ Edie Y. Chan; Anne M. Larson; Terry B. Gernsheimer; Kris V. Kowdley; Robert L. C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

Acute cellular graft-vs.-host disease (GVHD) following liver transplantation has an incidence of 1 to 2% and a mortality rate of 85%. Our aim was to identify a patient population at high risk for developing GVHD using a large clinical database to study both recipient and donor factors. We compared o

Impact of tacrolimus versus cyclosporine

Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: A prospective, randomized trial

✍ Paul Martin; Ronald W. Busuttil; Robert M. Goldstein; Jeffrey S. Crippin; Goran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p

The impact of postreperfusion syndrome o

The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation

✍ Ibtesam Hilmi; Charles N. Horton; Raymond M. Planinsic; Tetsuro Sakai; Ramona Ni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

The greatest part of liver allograft injury occurs during reperfusion, not during the cold ischemia phase. The aim of this study, therefore, was to investigate how the severity of postreperfusion syndrome (PRS) influences short-term outcome for the patient and for the liver allograft. Over a 2-year

Impact of the duration of posttransplant

Impact of the duration of posttransplant renal replacement therapy on bacterial infections in liver transplant recipients

✍ Hsin-Yun Sun; Thomas V. Cacciarelli; Marilyn M. Wagener; Nina Singh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Whether the duration of renal replacement therapy (RRT) after liver transplantation influences the rate and types of bacterial infections is not known. In this study, 47 of 299 consecutive liver transplant recipients (16%) required posttransplant RRT. The incidence of bacterial infections was higher